Cardiac marker troponin I could become new "gold standard"
This article was originally published in Clinica
A US study has backed previous evidence that the cardiac marker troponin I should replace creatine kinase-MB (CK-MB) as the new "gold standard" biochemical test for diagnosing heart attack in patients with chest pain.
You may also be interested in...
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.